Umetrics Suite Blog

Tiffany McLeod

Tiffany McLeod
Tiffany McLeod is the (Bio)pharma Market Manager within the Sartorius Stedim Data Analytics marketing team. She has been employed by Sartorius since 2017. Within this function Tiffany acts as the teams’ subject matter expert for life science market trends and requirements. She also works to addresses and develop data analytics solutions to solve industry challenges. She is passionate about biopharma 4.0 and helping businesses pursue digital transformations. Tiffany holds a degree in Bioengineering and Bioinformatics from the University of California, San Diego.

Recent Posts

Why DOE Is Essential in the (Bio)Pharma Industry

October 14, 2020

For pharmaceutical and biopharma companies, building quality into your products from an early stage is a key factor in regulatory approval and market success. Design of Experiments (DOE) is an essential tool for achieving both regulatory compliance and faster time to market.

Read More

The Trending Role of Artificial Intelligence in the Pharmaceutical Industry

August 18, 2020

Over the last several years, the use of artificial intelligence (AI) in the pharma and biomedical industry has gone from science fiction to science fact. Increasingly, pharma and biotech companies are adopting more efficient, automated processes that incorporate data-driven decisions and use predictive analytics tools. The next evolution of this approach to advanced data analytics incorporates artificial intelligence and machine learning.

Read More

Using Data Analytics to Accelerate COVID-19 Vaccine Development

July 23, 2020

In the midst of a global COVID-19 pandemic, a top priority for many pharma and biopharma companies is to get a vaccine developed, produced and delivered to the public as quickly as possible. Ushering a vaccine through rigorous testing protocols and regulatory approvals is not an easy (or quick) effort, but incorporating advanced data analytics could help accelerate the process. Data analytics has proven effective in speeding vaccine development both by enabling more efficient Design of Experiments (DOE) and by creating rapid-scale production rollout processes.

Read More

How to Make Sure You Have the Right Tools for Your Digital Transformation Process

June 25, 2020

Digital transformation in biopharma promises to deliver exponential results and make new discoveries and solutions to complex problems a reality, but it requires companies to make big changes to get there—changes in processes as well as adoption of new technologies. For some companies and facilities, this is a bigger leap than for others. Depending on the level of digitalization and integration that currently exists within a company, the process can take from months to years.

Read More

What Does Digital Transformation in Biopharma Look Like?

June 18, 2020

Digital transformation in biopharma, like other industries, is accelerating as Pharma 4.0 and Industry 4.0 begin to take shape in companies of all sizes. But knowing that digital transformation is inevitable is one thing, successfully managing the transition process is another. What are the steps biopharma companies should be taking to ensure a smooth digital transformation?

Read More

Is Your Company Ready for Digital Transformation and Biopharma 4.0?

May 19, 2020

From employing artificial intelligence (AI) to identify drug candidates to using big data to support continuous process manufacturing, the prospects for digital transformation in the biopharma industry are huge. Yet, biopharma and life sciences lag behind many other industries when it comes to digital transformation.

Read More

Search the Blog

    Subscribe to the Blog

    View the:

    Data Analytics Glossary of Terms

    List of Webinars

    Get a free trial